Cargando…
Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms
PURPOSE: Dry eye disease (DED) is often managed with over-the-counter eye drops. This study evaluated the diurnal effects of a single drop of two ocular lubricants (nanoemulsion vs. non-emollient) on tear film lipid layer thickness (LLT) and symptoms of ocular dryness. Subjects were also assessed af...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752989/ https://www.ncbi.nlm.nih.gov/pubmed/32359936 http://dx.doi.org/10.1016/j.optom.2020.03.002 |
_version_ | 1783625974934405120 |
---|---|
author | Weisenberger, Kimberly Fogt, Nick Swingle Fogt, Jennifer |
author_facet | Weisenberger, Kimberly Fogt, Nick Swingle Fogt, Jennifer |
author_sort | Weisenberger, Kimberly |
collection | PubMed |
description | PURPOSE: Dry eye disease (DED) is often managed with over-the-counter eye drops. This study evaluated the diurnal effects of a single drop of two ocular lubricants (nanoemulsion vs. non-emollient) on tear film lipid layer thickness (LLT) and symptoms of ocular dryness. Subjects were also assessed after 1 month of nanoemulsion eye drop use. METHODS: Part 1 was a cross-over comparison of a nanoemulsion and a non-emollient eye drop. LLT and dry eye symptoms were measured at baseline and at 15 min, 1 h, 2 h, 4 h and 6 h after instillation of each drop. Part 2 was a 1-month observational study assessing LLT and symptoms after 30-day use of the nanoemulsion drop four times daily (qid). RESULTS: Total of 20 subjects completed the study (mean age = 45.6 ± 7.9, 15 female). Part 1 found a significant increase in average LLT 15 min after nanoemulsion drop instillation in the overall and inferior third of the tear film for subjects with baseline LLT values <50 nm. Average LLT values did not increase after use of the non-emollient. Symptoms of dryness improved up to 6 h following instillation of both drops. Part 2 results found that using the nanoemulsion eye drop for 1 month improved symptoms reported on symptom surveys. CONCLUSION: Nanoemulsion eye drop use increased average LLT in subjects with low baseline levels. Statistically and clinically significant improvement in symptoms were found on symptom surveys after qid-use (four times a day) of the nanoemulsion drop. Results suggest that a nanoemulsion eye drop can benefit subjects with dry eye symptoms. |
format | Online Article Text |
id | pubmed-7752989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77529892020-12-23 Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms Weisenberger, Kimberly Fogt, Nick Swingle Fogt, Jennifer J Optom Original Article PURPOSE: Dry eye disease (DED) is often managed with over-the-counter eye drops. This study evaluated the diurnal effects of a single drop of two ocular lubricants (nanoemulsion vs. non-emollient) on tear film lipid layer thickness (LLT) and symptoms of ocular dryness. Subjects were also assessed after 1 month of nanoemulsion eye drop use. METHODS: Part 1 was a cross-over comparison of a nanoemulsion and a non-emollient eye drop. LLT and dry eye symptoms were measured at baseline and at 15 min, 1 h, 2 h, 4 h and 6 h after instillation of each drop. Part 2 was a 1-month observational study assessing LLT and symptoms after 30-day use of the nanoemulsion drop four times daily (qid). RESULTS: Total of 20 subjects completed the study (mean age = 45.6 ± 7.9, 15 female). Part 1 found a significant increase in average LLT 15 min after nanoemulsion drop instillation in the overall and inferior third of the tear film for subjects with baseline LLT values <50 nm. Average LLT values did not increase after use of the non-emollient. Symptoms of dryness improved up to 6 h following instillation of both drops. Part 2 results found that using the nanoemulsion eye drop for 1 month improved symptoms reported on symptom surveys. CONCLUSION: Nanoemulsion eye drop use increased average LLT in subjects with low baseline levels. Statistically and clinically significant improvement in symptoms were found on symptom surveys after qid-use (four times a day) of the nanoemulsion drop. Results suggest that a nanoemulsion eye drop can benefit subjects with dry eye symptoms. Elsevier 2021 2020-04-28 /pmc/articles/PMC7752989/ /pubmed/32359936 http://dx.doi.org/10.1016/j.optom.2020.03.002 Text en © 2020 Spanish General Council of Optometry. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Weisenberger, Kimberly Fogt, Nick Swingle Fogt, Jennifer Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
title | Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
title_full | Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
title_fullStr | Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
title_full_unstemmed | Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
title_short | Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
title_sort | comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752989/ https://www.ncbi.nlm.nih.gov/pubmed/32359936 http://dx.doi.org/10.1016/j.optom.2020.03.002 |
work_keys_str_mv | AT weisenbergerkimberly comparisonofnanoemulsionandnonemollientartificialtearsontearlipidlayerthicknessandsymptoms AT fogtnick comparisonofnanoemulsionandnonemollientartificialtearsontearlipidlayerthicknessandsymptoms AT swinglefogtjennifer comparisonofnanoemulsionandnonemollientartificialtearsontearlipidlayerthicknessandsymptoms |